rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Firat Ileri

Director and 10% owner

Company insider

Files Form 4 as: Director and 10% owner, BillionToOne.

In numbers

Trades disclosed
32
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
6 Nov 2025
Last trade
10 Jun 2026
Last filed
12 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
BLLN BillionToOneDirector, 10% owner · Diagnostics & Labs · last 10 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
10 Jun 2026filed 12 Jun 2026BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Code A—3,017 at $0.00filing
10 Jun 2026filed 12 Jun 2026BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Code A—3,017 at $0.00filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—28,981filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—640,727filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—18,845filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—1,569,015filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—446,103filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—20,000filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—33,000filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—2,261,377filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—137,288filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—2,260,520filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—320,363filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Code C—28,981filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Code C—640,727filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Code C—18,845filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Code C—2,015,118filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Code C—2,451,665filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Code C—2,580,833filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Code J—37,314filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Thomas P. LynchOfficer · Officer at BillionToOne, filing Form 4 there in the last year
Oguzhan AtayChairman and CEO · Chairman and CEO at BillionToOne, filing Form 4 there in the last year
John Roderick ten BoschSVP of Laboratory Operations · SVP of Laboratory Operations at BillionToOne, filing Form 4 there in the last year
David TsaoChief Technology Officer · Chief Technology Officer at BillionToOne, filing Form 4 there in the last year
Shan Riku SakakibaraChief Product Officer · Chief Product Officer at BillionToOne, filing Form 4 there in the last year